Malignant Hepatobiliary Neoplasm — Trials

Malignant Hepatobiliary Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,025 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,159
Recruiting: 665
Ph III recruiting: 61
Growth YoY: +9%
Industry share: 22%
Top sponsor: Sun Yat-sen University
Termination share: 32.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (560)

clinicaltrialsPublishedShowing 1–50 of 329 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06605664	Hyperpolarized 13C-MRI in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy, Atezolizumab, and Bevacizumab	recruiting	Phase 2	45	Chang Gung Memorial HospitalOTHER	1	Sep 29, 2026	clinicaltrials
NCT07847710	Perioperative Retlirafusp Alfa(Anti-PD-L1/TGF-β Bifunctional Fusion Protein) Plus Famitinib and GEMOX-Based Hepatic Arterial Infusion Chemotherapy for Locally Advanced Intrahepatic Cholangiocarcinoma: A Multicenter, Single-Arm, Exploratory Phase II Trial(H-FROG)	recruiting	Phase 2	81	The First Affiliated Hospital with Nanjing Medical University